Anthim
obiltoxaximab
Listed by Elusys Therapeutics, Inc.
- Strength
- 100 mg/mL
- Form
- Solution
- Route
- Intravenous
- Class
- Anthrax Protective Antigen-directed Antibody
What it contains
- Obiltoxaximab 100 mg/mL
FDA record
| Dosage form | Solution |
|---|---|
| Route | Intravenous |
| Drug class | Anthrax Protective Antigen-directed Antibody |
| Approval route | BLA — biologic licence |
| NDC code | 69604-204 |
| FDA application | BLA125509 |
| RxNorm concept | 1746910 |
| Package sizes listed | 1 |
| Marketed since | March 2016 |
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.